EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary

Sapna P Patel iD, Rahul A Sheth iD, Christina Davis, Theresa Medina

Journal of Clinical Oncology · 2025

DOI: 10.1200/jco-24-01802 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Oncology, 2025. Verfasst von Sapna P Patel und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado Cancer Center, Aurora, CO. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Immunotherapy, Ipilimumab, Melanoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology , to patients seen in their own clinical practice .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsImmunotherapyIpilimumabMelanomaNeoplasms, Unknown PrimaryNivolumabSkin NeoplasmsHumansMaleAdult

Substanzen

IpilimumabNivolumab

Autor:innen und Institutionen

  • University of Colorado Cancer Center, Aurora, CO.
  • The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: Sapna P Patel, Rahul A Sheth

Zitieren

APA

Patel, S. P., Sheth, R. A., Davis, C., & Medina, T. (2025). Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01802

Vancouver

Patel SP, Sheth RA, Davis C, Medina T. Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary. Journal of Clinical Oncology. 2025. doi:10.1200/jco-24-01802

BibTeX
@article{Patel2025,
  author = {Patel, Sapna P and Sheth, Rahul A and Davis, Christina and Medina, Theresa},
  title = {Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1200/jco-24-01802}
}
Kostenlos starten →